Abstract
We were motivated to discover whether our small signatures triangulate patient cohort relationships between intron and mRNA or protein. We tested biological outcomes using the signatures and intend to use it to screen cells for use in autologous and allogeneic immunotherapies.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.